Jonathan Freve

Chief Financial Officer, F-star Therapeutics, Inc.

Companies

Damora Therapeutics, Inc.Chief financial officer Oct 28, 2020 to Jan 5, 2024¹
F-star Therapeutics, Inc.Chief financial officer May 5, 2016 to Mar 9, 2020²
F-star Therapeutics, Inc.Board member Nov 23, 2016 to Nov 23, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Damora Therapeutics, Inc. DMRA12,000 shares⁴$219.8K at $18.32Dec 3, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 3, 2021Bought 4,000 shares at $2.49 of Damora Therapeutics, Inc.⁴
Nov 8, 2021Bought 3,000 shares at $3.40 of Damora Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDamora Therapeutics, Inc., Chief financial officer
2
SEC EDGARF-star Therapeutics, Inc., Chief financial officer
3
SEC EDGARF-star Therapeutics, Inc., Board member
4
SEC EDGARDamora Therapeutics, Inc. shares after the filing of Dec 3, 2021
5
SEC EDGARForm 4 filed Nov 9, 2021